| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |